Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chromocell Therapeutics Corp CHRO

Chromocell Therapeutics Corporation is a clinical-stage biotech company, which is focused on developing and commercializing therapeutics to alleviate pain. The Company's clinical focus is to selectively target the sodium ion-channel, NaV1.7, as well as other receptors in the NaV family. Its lead compound, CC8464, is designed to address both the underlying condition and mitigate the burning pain... see more

Recent & Breaking News (NYSEAM:CHRO)

    Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

    GlobeNewswire 9 days ago

    Chromocell to Present at Upcoming Fall Investor Conferences

    GlobeNewswire 10 days ago

    Chromocell Announces Amendment to Stock Repurchase Plan

    GlobeNewswire October 24, 2024

    Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference

    GlobeNewswire September 3, 2024

    Chromocell Announces Stock Repurchase Plan

    GlobeNewswire August 7, 2024

    Chromocell to Participate in the Virtual Investor Lunch Break Series

    GlobeNewswire July 15, 2024

    Chromocell To Present at Alliance Global Partner's Healthcare Company Showcase on Tuesday, May 21, 2024

    GlobeNewswire May 13, 2024

    Chromocell Issues Letter to Stockholders from Chief Executive Officer

    GlobeNewswire April 9, 2024

    Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

    GlobeNewswire March 21, 2024

    Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

    GlobeNewswire March 18, 2024

    Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

    GlobeNewswire March 11, 2024

    Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions

    GlobeNewswire February 27, 2024

    Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

    GlobeNewswire February 21, 2024

    Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

    GlobeNewswire February 16, 2024